Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 36576 - 36600 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Entinostat	Investigational	ASNS	440	upregulated	entinostat results in increased expression of ASNS mRNA	7q21.3	A21037
Entinostat	Investigational	ASPHD1	253982	upregulated	entinostat results in increased expression of ASPHD1 mRNA	16p11.2	A21035
Entinostat	Investigational	ASPN	54829	upregulated	entinostat results in increased expression of ASPN mRNA	9q22.31	A21035
Entinostat	Investigational	ASS1	445	upregulated	entinostat results in increased expression of ASS1 mRNA	9q34.11	A21037
Entinostat	Investigational	ASTN1	460	downregulated	entinostat results in decreased expression of ASTN1 mRNA	1q25.2	A21037
Entinostat	Investigational	ASXL3	80816	downregulated	entinostat results in decreased expression of ASXL3 mRNA	18q12.1	A21037
Entinostat	Investigational	ATAD2B	54454	downregulated	entinostat results in decreased expression of ATAD2B mRNA	2p24.1-p23.3	A21035
Entinostat	Investigational	ATF5	22809	upregulated	entinostat results in increased expression of ATF5 mRNA	19q13.33	A21037
Entinostat	Investigational	ATL1	51062	downregulated	entinostat results in decreased expression of ATL1 mRNA	14q22.1	A21037
Entinostat	Investigational	ATP10D	57205	upregulated	entinostat results in increased expression of ATP10D mRNA	4p12	A21035
Entinostat	Investigational	ATP1B2	482	upregulated	entinostat results in increased expression of ATP1B2 mRNA	17p13.1	A21037 A21035
Entinostat	Investigational	ATP23	91419	upregulated	entinostat results in increased expression of ATP23 mRNA	12q14.1	A21037
Entinostat	Investigational	ATP2A3	489	upregulated	entinostat results in increased expression of ATP2A3 mRNA	17p13.2	A21037 A21035
Entinostat	Investigational	ATP2B1-AS1	338758	downregulated	entinostat results in decreased expression of ATP2B1-AS1 mRNA	12q21.33	A21037
Entinostat	Investigational	ATP2B1-AS1	338758	upregulated	entinostat results in increased expression of ATP2B1-AS1 mRNA	12q21.33	A21035
Entinostat	Investigational	ATP2C2	9914	upregulated	entinostat results in increased expression of ATP2C2 mRNA	16q24.1	A21037
Entinostat	Investigational	ATP5S	27109	downregulated	entinostat results in decreased expression of ATP5S mRNA	14q21.3	A21037
Entinostat	Investigational	ATP6AP1L	92270	upregulated	entinostat results in increased expression of ATP6AP1L mRNA	5q14.2	A21035
Entinostat	Investigational	ATP6V0A2	23545	downregulated	entinostat results in decreased expression of ATP6V0A2 mRNA	12q24.31	A21037
Entinostat	Investigational	ATP6V1C2	245973	upregulated	entinostat results in increased expression of ATP6V1C2 mRNA	2p25.1	A21035
Entinostat	Investigational	ATP7A	538	downregulated	entinostat results in decreased expression of ATP7A mRNA	Xq21.1	A21037
Entinostat	Investigational	ATP8B1	5205	upregulated	entinostat results in increased expression of ATP8B1 mRNA	18q21.31	A21037
Entinostat	Investigational	ATP8B3	148229	upregulated	entinostat results in increased expression of ATP8B3 mRNA	19p13.3	A21037 A21035
Entinostat	Investigational	ATP8B4	79895	upregulated	entinostat results in increased expression of ATP8B4 mRNA	15q21.2	A21035
Entinostat	Investigational	AVEN	57099	downregulated	entinostat results in decreased expression of AVEN mRNA	15q14	A21035

Displaying entries 36576 - 36600 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability